Validation of a Questionnaire for Assessing the Emotional Impact of Treatment for Type 2 Diabetes
The EIDTQ-Status had strong factor structure with three subscales and a total score that demonstrated good reliability and validity. This questionnaire may be useful in clinical trials and observational research assessing the emotional impact of treatment for T2D.
Authors
- Kristina Secnik Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
- Louis S. Matza (ORCID: https://orcid.org/0000-0001-6374-5948)
- Karin S. Coyne (ORCID: https://orcid.org/0000-0002-5773-131X)
- Katelyn N. Cutts
Institutions
- Eli Lilly (United States) (US)
- Thermo Fisher Scientific (United States) (US)
Publication Details
- Journal
- Patient Related Outcome Measures
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/prom.s536043
- Primary Topic
- Diabetes Management and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company